HopeStage
Back to all studies
CompletedNCT02722967

Support Calls for Digital Aripiprazole Use in Schizophrenia, Depression and Bipolarity

About this titleRead the official source — NCT02722967
Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Granada Hills and 3 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMarch 2016
Recruitment status
Completed
Enrollment listed in the registry
49
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT02722967
Official title
Show the full official title

A Multicenter, 8-week, Open-label, Single-Arm Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System by Adult Subjects With Schizophrenia, Major Depressive Disorder, or Bipolar 1 Treated With Oral Aripiprazole

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Granada Hills · Rochester · Durham

1 more locations
  • Richmond

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Otsuka Pharmaceutical Development & Commercialization, Inc., a pharmaceutical company.

Did this study involve medication?

Yes. The study involved medication, including Aripiprazole + IEM (Ingestible Event Marker).

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies